Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.01
ACHC's Cash-to-Debt is ranked lower than
97% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. ACHC: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
ACHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.01
Equity-to-Asset 0.37
ACHC's Equity-to-Asset is ranked lower than
69% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. ACHC: 0.37 )
Ranked among companies with meaningful Equity-to-Asset only.
ACHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.39 Max: 0.56
Current: 0.37
0.22
0.56
Interest Coverage 2.24
ACHC's Interest Coverage is ranked lower than
86% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. ACHC: 2.24 )
Ranked among companies with meaningful Interest Coverage only.
ACHC' s Interest Coverage Range Over the Past 10 Years
Min: 2.1  Med: 2.98 Max: 9.7
Current: 2.24
2.1
9.7
Piotroski F-Score: 5
Altman Z-Score: 1.28
Beneish M-Score: -2.53
WACC vs ROIC
5.33%
6.27%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.56
ACHC's Operating Margin % is ranked higher than
72% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. ACHC: 14.56 )
Ranked among companies with meaningful Operating Margin % only.
ACHC' s Operating Margin % Range Over the Past 10 Years
Min: -17.77  Med: 15.36 Max: 17.24
Current: 14.56
-17.77
17.24
Net Margin % 0.54
ACHC's Net Margin % is ranked lower than
76% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. ACHC: 0.54 )
Ranked among companies with meaningful Net Margin % only.
ACHC' s Net Margin % Range Over the Past 10 Years
Min: -16.12  Med: 5.97 Max: 10
Current: 0.54
-16.12
10
ROE % 0.66
ACHC's ROE % is ranked lower than
79% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. ACHC: 0.66 )
Ranked among companies with meaningful ROE % only.
ACHC' s ROE % Range Over the Past 10 Years
Min: -72.42  Med: 8.25 Max: 12.2
Current: 0.66
-72.42
12.2
ROA % 0.24
ACHC's ROA % is ranked lower than
75% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. ACHC: 0.24 )
Ranked among companies with meaningful ROA % only.
ACHC' s ROA % Range Over the Past 10 Years
Min: -16.9  Med: 3.2 Max: 4.84
Current: 0.24
-16.9
4.84
ROC (Joel Greenblatt) % 13.86
ACHC's ROC (Joel Greenblatt) % is ranked lower than
59% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. ACHC: 13.86 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ACHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -76.52  Med: 20.4 Max: 36.41
Current: 13.86
-76.52
36.41
3-Year Revenue Growth Rate 32.10
ACHC's 3-Year Revenue Growth Rate is ranked higher than
95% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. ACHC: 32.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ACHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 16.3  Med: 33.85 Max: 59.1
Current: 32.1
16.3
59.1
3-Year EBITDA Growth Rate 30.50
ACHC's 3-Year EBITDA Growth Rate is ranked higher than
87% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. ACHC: 30.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ACHC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 30.5  Med: 40.7 Max: 82.2
Current: 30.5
30.5
82.2
3-Year EPS without NRI Growth Rate -56.70
ACHC's 3-Year EPS without NRI Growth Rate is ranked lower than
96% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. ACHC: -56.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ACHC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.7  Med: 31.3 Max: 45.7
Current: -56.7
-56.7
45.7
» ACHC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-23 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

ACHC Guru Trades in Q2 2016

Steven Cohen 233,300 sh (New)
Manning & Napier Advisors, Inc 184,200 sh (+13.82%)
Alan Fournier 1,631,511 sh (+7.44%)
RS Investment Management 644,586 sh (+2.63%)
Vanguard Health Care Fund 1,806,200 sh (unchged)
Paul Tudor Jones Sold Out
Jim Simons 65,315 sh (-76.72%)
» More
Q3 2016

ACHC Guru Trades in Q3 2016

Steven Cohen 508,247 sh (+117.85%)
Manning & Napier Advisors, Inc 281,040 sh (+52.57%)
Vanguard Health Care Fund 2,642,495 sh (+46.30%)
Alan Fournier 2,011,211 sh (+23.27%)
Jim Simons Sold Out
» More
Q4 2016

ACHC Guru Trades in Q4 2016

Joel Greenblatt 290,572 sh (New)
Jim Simons 970,500 sh (New)
Richard Snow 25,000 sh (New)
Alan Fournier 3,210,062 sh (+59.61%)
Vanguard Health Care Fund 3,608,655 sh (+36.56%)
Manning & Napier Advisors, Inc 377,100 sh (+34.18%)
Steven Cohen 445,700 sh (-12.31%)
» More
Q1 2017

ACHC Guru Trades in Q1 2017

Manning & Napier Advisors, Inc 224,340 sh (-40.51%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:ACHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:HLS, NYSE:CHE, NAS:LPNT, OTCPK:LTGHY, NAS:SCAI, NYSE:MD, NYSE:AMN, OTCPK:CAKFY, NAS:AMED, NYSE:SEM, NYSE:THC, NAS:TVTY, NYSE:EVHC, NYSE:CYH, NAS:LHCG, NAS:SGRY, NYSE:USPH, OTCPK:SKHCF, NAS:AFAM, NAS:PRSC » details
Traded in other countries:7RA.Germany,
Headquarter Location:USA
Acadia Healthcare Co Inc develops and operates inpatient psychiatric facilities, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Acadia Healthcare Company Inc functions in the United States healthcare sector. It manages behavioural health primarily through the U.S region. Additionally, it operates through the U.K market. The company's properties comprise of psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioural healthcare services across the United States and the United Kingdom.

Top Ranked Articles about Acadia Healthcare Co Inc

Acadia Healthcare Announces Date for First Quarter 2017 Earnings Release
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions Solid growth has attended the sector until this year
Against a backdrop of solid growth for the sector, the outperforming Vanguard Health Care Fund (Trades, Portfolio) replenished its portfolio in the first quarter with increases in 27 holdings and reductions or removal of 28 holdings. Read more...

Ratios

vs
industry
vs
history
PE Ratio 242.11
ACHC's PE Ratio is ranked lower than
100% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. ACHC: 242.11 )
Ranked among companies with meaningful PE Ratio only.
ACHC' s PE Ratio Range Over the Past 10 Years
Min: 27.14  Med: 48.31 Max: 575.78
Current: 242.11
27.14
575.78
Forward PE Ratio 17.79
ACHC's Forward PE Ratio is ranked higher than
58% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 18.73 vs. ACHC: 17.79 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 242.11
ACHC's PE Ratio without NRI is ranked lower than
100% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 28.00 vs. ACHC: 242.11 )
Ranked among companies with meaningful PE Ratio without NRI only.
ACHC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 27.14  Med: 48.11 Max: 575.78
Current: 242.11
27.14
575.78
PB Ratio 1.71
ACHC's PB Ratio is ranked higher than
69% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. ACHC: 1.71 )
Ranked among companies with meaningful PB Ratio only.
ACHC' s PB Ratio Range Over the Past 10 Years
Min: 1.34  Med: 3.32 Max: 5.75
Current: 1.71
1.34
5.75
PS Ratio 1.31
ACHC's PS Ratio is ranked higher than
58% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. ACHC: 1.31 )
Ranked among companies with meaningful PS Ratio only.
ACHC' s PS Ratio Range Over the Past 10 Years
Min: 0.67  Med: 2.5 Max: 3.74
Current: 1.31
0.67
3.74
Price-to-Free-Cash-Flow 59.21
ACHC's Price-to-Free-Cash-Flow is ranked lower than
97% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. ACHC: 59.21 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ACHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 35.87  Med: 86.52 Max: 330.44
Current: 59.21
35.87
330.44
Price-to-Operating-Cash-Flow 10.48
ACHC's Price-to-Operating-Cash-Flow is ranked higher than
67% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. ACHC: 10.48 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ACHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.87  Med: 29.32 Max: 45.83
Current: 10.48
7.87
45.83
EV-to-EBIT 16.89
ACHC's EV-to-EBIT is ranked higher than
52% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. ACHC: 16.89 )
Ranked among companies with meaningful EV-to-EBIT only.
ACHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -221.7  Med: 25.1 Max: 138.5
Current: 16.89
-221.7
138.5
EV-to-EBITDA 12.64
ACHC's EV-to-EBITDA is ranked higher than
54% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. ACHC: 12.64 )
Ranked among companies with meaningful EV-to-EBITDA only.
ACHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -32.6  Med: 21.5 Max: 651.1
Current: 12.64
-32.6
651.1
Current Ratio 1.26
ACHC's Current Ratio is ranked lower than
52% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. ACHC: 1.26 )
Ranked among companies with meaningful Current Ratio only.
ACHC' s Current Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.41 Max: 4.38
Current: 1.26
0.93
4.38
Quick Ratio 1.25
ACHC's Quick Ratio is ranked higher than
53% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. ACHC: 1.25 )
Ranked among companies with meaningful Quick Ratio only.
ACHC' s Quick Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.41 Max: 4.38
Current: 1.25
0.93
4.38
Days Inventory 0.40
ACHC's Days Inventory is ranked higher than
95% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. ACHC: 0.40 )
Ranked among companies with meaningful Days Inventory only.
ACHC' s Days Inventory Range Over the Past 10 Years
Min: 0.4  Med: 0.92 Max: 1.02
Current: 0.4
0.4
1.02
Days Sales Outstanding 35.07
ACHC's Days Sales Outstanding is ranked higher than
60% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. ACHC: 35.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
ACHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.19  Med: 46.56 Max: 59.22
Current: 35.07
34.19
59.22
Days Payable 19.95
ACHC's Days Payable is ranked lower than
79% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. ACHC: 19.95 )
Ranked among companies with meaningful Days Payable only.
ACHC' s Days Payable Range Over the Past 10 Years
Min: 17.61  Med: 27.69 Max: 31.62
Current: 19.95
17.61
31.62

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -20.50
ACHC's 3-Year Average Share Buyback Ratio is ranked lower than
84% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. ACHC: -20.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ACHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -41.6  Med: -21.55 Max: -12.3
Current: -20.5
-41.6
-12.3

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.50
ACHC's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
66% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. ACHC: 2.50 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ACHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.96  Med: 2.77 Max: 3.05
Current: 2.5
1.96
3.05
Price-to-Median-PS-Value 0.53
ACHC's Price-to-Median-PS-Value is ranked higher than
90% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. ACHC: 0.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ACHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.33  Med: 1 Max: 1.42
Current: 0.53
0.33
1.42
Earnings Yield (Greenblatt) % 5.92
ACHC's Earnings Yield (Greenblatt) % is ranked higher than
59% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. ACHC: 5.92 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ACHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.7  Med: 3.8 Max: 6.5
Current: 5.92
0.7
6.5

More Statistics

Revenue (TTM) (Mil) $2,873
EPS (TTM) $ 0.18
Beta0.83
Short Percentage of Float51.46%
52-Week Range $32.54 - 65.00
Shares Outstanding (Mil)87.82

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 2,884 3,112 3,355
EPS ($) 2.46 2.90 3.32
EPS without NRI ($) 2.46 2.90 3.32
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for ACHC

Headlines

Articles On GuruFocus.com
Acadia Healthcare Announces Date for First Quarter 2017 Earnings Release Apr 13 2017 
Acadia Healthcare Set to Join the S&P MidCap 400 Apr 03 2017 
Alan Fournier Invests in Leidos Holdings, Bank of America Dec 05 2016 
Acadia Healthcare: It Makes Sense to Look Beyond the Brexit Effect Jun 27 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Weekly CFO Sells Highlight: Acadia Healthcare, Facebook, Regeneron Pharmaceuticals Aug 24 2015 
A Far-Larger Hospital and a Far-Larger Stock Position Jan 02 2014 
3 Best-Yielding Stocks Which Hit All-Time-Highs Recently Jun 19 2013 

More From Other Websites
Acadia Healthcare Co., Inc. :ACHC-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017 Apr 28 2017
Edited Transcript of ACHC earnings conference call or presentation 26-Apr-17 12:00pm GMT Apr 28 2017
Acadia Healthcare to Present at Three Upcoming Conferences Apr 27 2017
Acadia Healthcare Co., Inc. breached its 50 day moving average in a Bearish Manner : ACHC-US : April... Apr 27 2017
Acadia Healthcare (ACHC) Q1 Earnings In Line, View Intact Apr 26 2017
Acadia Healthcare meets 1Q profit forecasts Apr 25 2017
Acadia Healthcare Reports First Quarter GAAP EPS of $0.40 and Adjusted EPS of $0.46 Apr 25 2017
5 Earnings Short-Squeeze Plays: Twitter, Sarepta Therapeutics Included Apr 24 2017
Healthcare Earnings to Watch on Apr 25: ACHC, CNC & UHS Apr 24 2017
The Zacks Analyst Blog Highlights: Acadia Healthcare, Mednax and Tenet Healthcare Apr 19 2017
3 Hospital Stocks That Won't Make You Feel Better in Q1 Apr 18 2017
Acadia Healthcare Announces Date for First Quarter 2017 Earnings Release Apr 13 2017
ETFs with exposure to Acadia Healthcare Co., Inc. : April 7, 2017 Apr 07 2017
Should You Retain Acadia Healthcare Stock in Your Portfolio? Apr 05 2017
Acadia Healthcare Set to Join the S&P MidCap 400 Apr 03 2017
Private Equity Sees No End to the Drug and Mental-Health Gold Rush Mar 30 2017
Acadia Healthcare (ACHC) Down 3% Since Earnings Report: Can It Rebound? Mar 28 2017
Acadia Healthcare Co., Inc. breached its 50 day moving average in a Bullish Manner : ACHC-US : March... Mar 27 2017
Health Care Investors Attempt to Parse Trump Budget Mar 16 2017
The Zacks Analyst Blog Highlights: Acadia Healthcare, VCA, Universal Health Services and Mednax Mar 09 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)